InvestorsHub Logo
Followers 16
Posts 1267
Boards Moderated 0
Alias Born 01/24/2015

Re: LEX3 post# 22874

Friday, 10/12/2018 7:09:19 PM

Friday, October 12, 2018 7:09:19 PM

Post# of 27120
ACOL/MDTR run to $.05+ was early 2017. Per 10-k (Dec 17) O/S was 5,249,511,270. Per 10-q (Jun 19) total O/S was 5,524,636,434. We're seeing a record-setting volume ramp that has already spiked over what was seen in 2017 (~175M vs ~200M; set ihub chart to 2yr to see this). Only time will tell now if this level of trading is sustained for as long or longer than it was in 2017 of approx 1 month.
Way more catalysts, secured int prop/patents, and successful sales records from then to now makes this stock play much more appealing and is likely to achieve new heights (I hope) even though share count did, in fact, increase which is what I think you were asking. Note-They had to buy the patents with something. Those new shares are already open trading and did not affect restricted shares held by company.
Good company track record so far, rumors abound though (especially with this latest movement starting with a spike to 200M day), now it just needs to play out into the news, legislation, and let the markets answer.

Good luck to all, playing it as we see it.
IMO.